Growth of 9 per cent and strengthened market position through more partners
January 1 - December 31, 2012
* Net sales increased by 9 % to SEK 169.5 million (155.4).
* Operating profit increased to SEK 20.7 million (17.8).
* Profit before tax increased to SEK 18.6 million (18.5).
* Earnings per share were SEK 0.27 (0.61).1
* Cash and cash equivalents were SEK 46.2 million (56.8) at the end of the period.
* Global distribution agreement with one more partner, Siemens.
* Increased activities in China; a market office in Shanghai has been established.
* New system for veterinary medicine in North America - first order received.
* New tool for small laboratories in networks launched,
CellaVision® Image Capture System.
* The Board of Directors proposes an unchanged dividend of SEK 0.40 per share for 2012.
